Anais is investigating the effects of targeting tumor metabolism, specifically mitochondria bioenergetics and hypoxia, and its impact on the regulation of anti-tumor immune responses. Her goal is to increase the efficacy of anticancer treatments, including radiotherapy and immune checkpoint blockade (anti-PD-1/anti-PD-L1, CTLA-4). She focuses on breast cancer and melanoma, which she uses as model systems for her studies.